Company
Foresite Capital
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Thyme Care | Series E | 2026-09-02 | |
| Khartis Therapeutics | Series B | 2026-08-13 | |
| Pinnacle Medicines | Series B | 2026-03-26 | Lead |
| Midi Health | Series D | 2026-02-03 | |
| Aeovian Pharmaceuticals | Funding | 2025-12-16 | |
| Indomo | Funding | 2025-11-03 | |
| Thyme Care | Series D | 2025-09-25 | |
| Avenzo Therapeutics | Series B | 2025-09-22 | |
| RayThera | Series A | 2025-04-07 | Lead |
| Latigo Biotherapeutics | Series B | 2025-03-17 | |
| Abcuro | Series C | 2025-02-13 | Lead |
| Pleno | Series B | 2024-12-12 | |
| Candid Therapeutics | Funding | 2024-09-09 | |
| Spear Bio | Series A Financing | 2024-07-29 | Lead |
| Thyme Care | Series C Funding | 2024-07-16 | |
| Element Biosciences, Inc | Series D Funding | 2024-07-11 | |
| Alumis | Series C Financing | 2024-03-07 | Lead |
| FogPharma | Series E Funding | 2024-03-03 | |
| Thyme Care | Series B Funding | 2023-08-22 | Lead |
| Foresight Diagnostics | Series B Funding | 2023-04-27 | Lead |
| Cerevance | Series B | 2023-02-13 | |
| Odyssey Therapeutics | Series B | 2022-10-13 | |
| Folx Health | Series B | 2022-10-12 | |
| Pleno | Series A | 2022-10-12 | |
| DELFI Diagnostics | Series B | 2022-07-18 |